ARGS
Argos Therapeutics, Inc.
ARGS
ARGS
Delisted
ARGS was delisted on the 24th of April, 2018.
46 hedge funds and large institutions have $31.3M invested in Argos Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 43 → 46 (+3)
Holders
46
Holding in Top 10
–
Calls
$1.07M
Puts
$169K
Top Buyers
| 1 | +$4.18M | |
| 2 | +$1.78M | |
| 3 | +$629K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$565K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$554K |
Top Sellers
| 1 | -$353K | |
| 2 | -$163K | |
| 3 | -$76.5K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$71.6K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$27.5K |